Cervical Cancer Diagnostic Market is Prospering at 15.94 Billion Globally by 2029, Size, Share, Emerging Trends, Key Growth Factors, Demand and Competitive Outlook

News provided by

Data Bridge Market Research

29 Nov, 2022, 17:00 GMT

SYDNEY, Nov. 29, 2022 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Cervical Cancer Diagnostic Market" The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This Cervical Cancer Diagnostic market research report is one of the unsurpassed and comprehensive market research reports which emphasize the challenges, market structures, opportunities, driving forces, emerging trends, and competitive landscape of Cervical Cancer Diagnostic industry. This market report acts as an authentic source of information which puts forth a telescopic view of the current market trends, situations, opportunities and status. Cervical Cancer Diagnostic report also gives explanation about strategic profiling of key players in the market, systematic analysis of their core competencies, and provides a competitive landscape for the market. What is more, it offers worth mentioning market data along with future forecast and thorough analysis of the market on a global and regional level.

Data Bridge Market Research analyses that the cervical cancer diagnostic market which was USD 10 billion in 2021, is expected to reach USD 15.94 billion by 2029, at a CAGR of 6.00% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Sample Copy of Cervical Cancer Diagnostic Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cervical-cancer-diagnostic-market

Market Overview:

Cervical cancer is a type of cancer that develops in the female reproductive tract's cervix. Cervical cancer is frequently defined by the irregular development of cancer cells in the tissue of the cervix. Adenocarcinoma or squamous cell carcinoma can develop from cervical cancer. The most common cause of cervical cancer is HPV (Human Papillomavirus) infection. Cervical cancer is classified into two types adenocarcinoma and squamous cell carcinoma. Cervical cancer is diagnosed using a variety of advanced laboratory tests, tools, and procedures that evaluate abnormal cells and strains of the human papillomavirus (HPV).

Cervical cancer is the fourth most common cancer in women worldwide, and the second most common cancer in women in developing countries. In 2012, the World Health Organization (WHO) estimated 530 000 new cases of cervical cancer worldwide, with approximately 270 000 deaths (representing 7.5% of all female cancer deaths). Over 85% of these fatalities occurred in low- and middle-income countries.

Recent developments

In May 2020, Becton, Dickinson & Co, a manufacturer and seller of medical devices, instrument systems, and reagents based in the United States, announced the acquisition of San Diego biomedical firm CareFusion for $12.2 billion. By identifying needs in hospitals, hospital pharmacies, and alternate sites of care, the acquisition is expected to improve patient care and lower health-care costs.

A comprehensive analysis will be provided covering the following points in the report:

  • Executive Market Summary
  • Scope of the Cervical Cancer Diagnostic Research Report
  • Key Finding and Recommendations
  • Growth and Investment Opportunities
  • Cervical Cancer Diagnostic Market Attractive Investment Proposition
  • Competitive landscape and SWOT Analysis
  • Cervical Cancer Diagnostic Market Segmentation Outlook
  • Regional Outlook
  • Company Profiles of Key Players

Some of the major players operating in the Cervical Cancer Diagnostic market are:

  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • QIAGEN (Germany)
  • Quest Diagnostics Incorporated. (U.S.)
  • Hologic, Inc. (U.S.)
  • Arbor Vita Corporation (U.S.)
  • Guided Therapeutics, Inc. (U.S.)
  • CooperSurgical Inc (U.S.)
  • BD (U.S.)
  • Cardinal Health (U.S.)
  • Siemens Healthcare Private Limited (Germany)
  • Zilico (U.K.)
  • GenomeMe Lab Inc. (Canada)
  • Exact Sciences Corporation (U.S.)
  • Fujirebio (Japan), Advaxis Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc. (U.K.)
  • Bristol-Myers Squibb Company (U.S.)
  • Merck & Co., Inc (U.S.)

Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-cervical-cancer-diagnostic-market

The Primary Objectives of This Global Market Research Report Are as Follows:

  • To understand this market competition by analysing the top vendors, with their market profile, revenue, profits, import-export details, and market share
  • To state the pricing structure, import-export details, supply chain analysis, SWOT analysis to facilitate the key decision-making process
  • To provide the complete structure and fundamental overview of Cervical Cancer Diagnostic Industry
  • To offer insights into vital this market aspect like growth trajectory, CAGR value, market share, and revenue analysis
  • To evaluate the growth opportunities, threats, market drivers, and risks involved
  • To boost the future growth, investment analysis and upcoming growth opportunities with the analysis of emerging market segments and sub-segments
  • To present the historic, present, and forecast market analysis with product developments, joint ventures, and strategic alliances
  • To study the recent developments, emerging sectors, new product launch events, and mergers & acquisitions in this market
  • To understand the data sources, implied research methodology, and vital conclusions

Opportunities

  • Increased use of HPV home testing kits

According to the World Health Organization, the two HPV types (16 and 18) cause 70% of cervical cancers and pre-cancerous cervical wounds, thus, administering the human papillomavirus (HPV) vaccine effectively reduces the number of cervical pre-cancerous wounds that may develop into cervical cancers. The market's new trend is expected to be the increased use of HPV home testing kits. Women can use home-based HPV testing kits to collect samples and obtain results without having to travel to a lab for screening. As a result, businesses are focusing on making the lives of patients easier. In January 2019, Nurx, a consumer health and telemedicine company, introduced lab testing that allows women to easily and affordably monitor their risk of cervical cancer from the comfort of their own homes. Similarly, Matter launched three conceptual cervical cancer examinations in April 2019 through the Sukha project, which helps women conduct tests at home to reduce the stigma associated with cervical testing. These all are the certain factors which is expected to propel the market.

Market Dynamics: Cervical Cancer Diagnostic Market

  • Rising awareness of cervical cancer

The growing use of cervical cancer diagnostic tests for early detection is expected to drive the cervical cancer diagnostics market. The growing awareness of cervical cancer among women, as well as the emphasis placed by global cancer organisations and governments on early detection and prevention, all contribute to the market's growth. For instance, the United States Preventive Services Task Force updated its cervical cancer screening guidelines in August 2019, stating that women aged 21 to 29 should be screened with a Pap test every 3 years, women aged 30 to 65 should be screened with any of three tests, namely high-risk HPV testing alone, Pap and high-risk HPV contesting every 5 years, and Pap test alone every 3 years. The market is being propelled by the increasing adoption of cervical cancer diagnostic tests and the emphasis on early detection.

  • Government Initiatives

Becton, Dickinson & Co, a manufacturer and seller of medical devices, instrument systems, and reagents based in the United States, announced the acquisition of San Diego biomedical firm CareFusion for $12.2 billion in May 2020. By identifying needs in hospitals, hospital pharmacies, and alternate sites of care, the acquisition is expected to improve patient care and lower health-care costs.

THANKSGIVING WEEK SALE!!!

Get UP TO 35%. OFF ON GLOBAL REPORTS. OFFER VALID TILL 30th NOV 2022

For More, Inquire at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cervical-cancer-diagnostic-market

Consider Data Bridge Market Research for this Report which would Help Impact Your Revenues Positively

  • This study offers the latest product news, trends, and updates from the industry's leading players who have leveraged their market position.
  • It also offers strategic plans and standards to arrive at informed business decisions adopted by the main players, thereby advocating you go to market strategies.
  • In addition, it offers insights into the dynamics of customer behaviour that can help the organization better curate market strategies
  • Usage of exclusive tailor-made tools along with primary research, secondary research and our in-house data model helps us in extracting the exact market numbers
  • Mapping the customer in 3P grid comprising of Purpose, Planning and Positioning, thereby delivering a solution by keeping the prospecting client at the sweet spot
  • The market research report includes all of the market's valuable elements, such as sales growth, product pricing & analysis, growth opportunities, and recommendations for addressing market challenges
  • The report covers all the primary mergers & acquisitions, alliances, and collaborations that have generated additional opportunities for market players or in some cases, challenges

Key Industry Segmentation: Cervical Cancer Diagnostic Market

Test Type

  • Pap Testing
  • HPV Testing
  • Colposcopy
  • Cervical Biopsies
  • Cystoscopy

 Treatment

 Age Group

  • Age Group Between 20 to 40
  • Age Group Above 40

 End Use

  • Hospitals and Clinics
  • Diagnostic Centres
  • Laboratories

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-cervical-cancer-diagnostic-market

Regional Analysis/Insights: Cervical Cancer Diagnostic Market

The countries covered in the cervical cancer diagnostic market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cervical cancer diagnostic market because of the high prevalence of cervical cancer patients, as well as the growing number of early detection programmes.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the growing incidence of cancer cases.

Table of Contents:

1.  Introduction

2.  Market Segmentation

3.  Executive Summary

4.  Premium Insights

5.  Global Cervical Cancer Diagnostic Market: Regulations

6.  Market Overview

7.  Global Cervical Cancer Diagnostic Market, By Test Type

8.  Global Cervical Cancer Diagnostic Market, By Treatment

9.  Global Cervical Cancer Diagnostic Market, By Age Group

10.  Global Cervical Cancer Diagnostic Market, By End Use

11.  Global Cervical Cancer Diagnostic Market, By Region

12.  Global Cervical Cancer Diagnostic Market: Company Landscape

13.  SWOT Analyses

14.  Company Profile

15.  Questionnaires

16.  Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-cervical-cancer-diagnostic-market

Explore More Reports:

Robotic Surgery for Cervical Cancer Market, By Robotic Surgery Component (Robotic Surgery System, Maintenance Service), End- Users (Hospitals, Research Centers, Laboratories, Others), Surgery Type (Cryosurgery, Laser Surgery, Simple Hysterectomy, Radical Hysterectomy, Trachelectomy, Others) https://www.databridgemarketresearch.com/reports/global-robotic-surgery-for-cervical-cancer-market

Cervical Cancer Drug Market, By Treatment Type (Surgery, Chemotherapy, Targeted Therapy, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-cervical-cancer-drug-market

Cervical Cancer Treatment Market, By Type (Squamous Cell Carcinoma, Adenocarcinoma), Treatment (Surgery, Radiation, Chemotherapy, Immunotherapy), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-cervical-cancer-treatment-market

Cervical Intraepithelial Neoplasia Drugs Market, By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, Cervical Intraepithelial Neoplasia 3), Treatment (Surgery, Medication, Others), Dosage Form (Solution, Powder, Injection, Cream, Others), Route of Administration (Intravenous, Topical, Others), Indication (Pre-malignant Lesions, Early Invasive Stage, Advanced Invasive Stage), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) https://www.databridgemarketresearch.com/reports/global-cervical-intraepithelial-neoplasia-drugs-market

Cervical Dilator Market, By Type (Metal, Plastic, Osmotic), Application(Diagnostic, Treatment), End User (Hospitals, Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-cervical-dilator-market

Cervical Retractors Market, By Type (Transverse Retractors, Longitudinal Retractors), End-User (Hospitals, Clinic, Others) https://www.databridgemarketresearch.com/reports/global-cervical-retractors-market

Anterior Cervical Fixation Devices Market, Type (Fixation Systems, Bone Grafts), Application (Hospital, Clinics, Others) https://www.databridgemarketresearch.com/reports/global-anterior-cervical-fixation-devices-market

Sleep Apnea Devices Market, By Diseases Type (Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome), Type (Devices, Therapy), Patient Demographics (Pediatric, Adult, Geriatric), End User (Hospital/ Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Centers, Home Healthcare), Distribution Channel (Direct Tender, Retail Sales) https://www.databridgemarketresearch.com/reports/global-sleep-apnea-devices-market

Probiotics Market, By Form (Liquid, Dry), Ingredient (Bacteria, Yeast), Application (Functional Food and Beverages, Dietary Supplements, Animal Feed), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, Online), End User (Human, Animal) https://www.databridgemarketresearch.com/reports/global-probiotics-market

Gene Synthesis Market, By Component (Synthesizer, Consumables, and Software & Services), Gene Type (Standard Gene, Express Gene, Complex Gene and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutics Antibodies, and Others), Method (Solid Phase Synthesis, Chip-Based DNA Synthesis, and PCR-Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostics Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distributors) https://www.databridgemarketresearch.com/reports/global-gene-synthesis-market

Telehealth Market, By Component (Services, Software, and Hardware), Mode of Delivery (Web-Based Delivery Mode, Cloud-Based Delivery Mode, and On-Premise Delivery Mode), End User (Providers, Payers, Patients, and Other End Users) https://www.databridgemarketresearch.com/reports/global-telehealth-market

Prostate Cancer Therapeutics Market, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales,  Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-prostate-cancer-therapeutics-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research 
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg